Search Within
Document Type
58-89-9
Applied Filters:
Keyword:'58-89-9'
Showing 1-30 of 256 results for "58-89-9" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
107 92 90 13 38 105 83 101 66 61 85 53 30 89 58 99 5 50 46
ROCK-II 0 13 7 88 88 94 107 80 77 61 91 104 55 92 101 102 92 90 89
The Effective Use of Protein Kinase Inhibitors
107 92 90 13 38 105 83 101 66 61 85 53 30 89 58 99 5 50 46
ROCK-II 0 13 7 88 88 94 107 80 77 61 91 104 55 92 101 102 92 90 89
SMC®Plate Washer Evaluation Kit
53 69 63 68 62 58 59 64 61 60 81 64 7 11
F 76 63 73 83 73 70 83 65 70 84 66 87 74 8 11
G 78 62 55 44 68 51 56
Impurities & Related Compounds: Reference Materials
14949-00-9
55079-83-9
54350-48-0
59277-89-3
106685-40-9
33626-98-1
106685-41-0
43109-77-9
932033-57-3
97540-22-2
58-61-7
58-96-8
58-63-9
51022-70-9
118-00-3
Product Information Sheet - Z2902
minutes 100% Alcohol 23 °C No
9 60 minutes Xylene 23 °C No
10 60 minutes Xylene 23 °C No
11 30 minutes Paraffin 58 °C Yes
12 60 minutes Paraffin 58 °C Yes
13 90 minutes Paraffin 58 °C Yes
After fixing, tissues
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
33 14 22 17 124 54 38 104 23 51 28 48 35 137 34
std 2 69 31 35 21 163 89 65 143 44 71 31 88 46 161 71
std 3 212 150 94 58
Using Empore C18 SPE Disk to Extract SVOCs in Drinking Water Followed by GC-MS Analysis for EPA Method 525.2
studied in this experiment. The average
recovery for 89 compounds exceeded 85% with average rela-
tive standard deviation (RSD) of 4.7%. The other 9 compounds
had recovery between 70% to 84%, with average
Optimize Your Cross-Coupling: The Phosphine Predictor
iPr)3
P
6476-36-4 377309
84 PallylPh2
P
2741-38-0 336874
89 tBuBrettPhos
PtBu2iPr
iPr
iPr
OMe
OMe 1160861-53-9 730998
102 BrettPhos
PtBu2iPr
iPr
iPr
OMe
OMe 1070663
Cerulenin (C2389)
in tumor cell lines.
Cancer Res., 58, 4611-4615 (1998).
7. Heiligtag, S.J. et al., Key role of mitochondria in
cerulenin-mediated apoptosis. Cell Death Differ., 9,
1017-1025 (2002).
8. Pereira
Data Sheet - SAB4200761
Neuroradiol., 26,
2560-8 (2005).
9. Satelli A and Shulin L., Cell Mol Life Sci., 68,
3033-46 (2011).
10. Challa AA and Stefanovic B., Mol Cell Biol., 31,
3773-89 (2011).
11. Dave JM
LABORATORY NOTEBOOK ISSUANCE PAGE
96
54
.9
38
55
.8
45
58
.9
33
54
.9
38
88
.9
06
91
.2
24
92
.9
06
95
.9
6
(9
8)
10
1.
07
10
2.
91
13
8.
91
17
LABORATORY NOTEBOOK ISSUANCE PAGE
96
54
.9
38
55
.8
45
58
.9
33
54
.9
38
88
.9
06
91
.2
24
92
.9
06
95
.9
6
(9
8)
10
1.
07
10
2.
91
13
8.
91
17
LABORATORY NOTEBOOK ISSUANCE PAGE
96
54
.9
38
55
.8
45
58
.9
33
54
.9
38
88
.9
06
91
.2
24
92
.9
06
95
.9
6
(9
8)
10
1.
07
10
2.
91
13
8.
91
17
Comparative Study - ReadyStream® Footprint Analysis vs others
-25% -89% -89% -100%
0.00
We have built a unique collection of life science brands with
unrivalled experience in supporting your scientific advancements.
Appendix
Figures 9 and 10
Antibiotics and Antimycotics
(3’-[a-Amino-p-
methoxyhydrocinnamamido]-3’-deoxy-
N,N-dimethyladenosine dihydrochloride)
CAS No. 58-58-2
C22H29N7O5 � 2HCl FW 544.4
powder, ‡98% (TLC), cell culture, tested
Nucleoside antibiotic. Protein
Application Note - Assurance GDS - Alternative confirmation E. coli O157:H7 &Salmonella
Reference Method
CHROMID® Salmonella 79 58 5 16 84 78
RAPID’Salmonella 78 61 2 17 80 74
Salmonella ChromoSelect 81 45 18 14 99 92
All three plates 89 44 19 6 108 100
Resuspension
Spare parts for Mobius® FlexReady Solution with Smart Flexware® Assemblies For Chromatography and TFF
83
88
20
Applicable for
200MOD2
84
85
86
89
90
91
94
90
94
84
91
20
88
86
83
85
Periodic Table of the Elements - Certipur ICP / AAS standards
.42Au
1, 3
[Xe] 4f145d106s1
80 200.59 –38.83
356.73
1.44Hg
1, 2
[Xe] 4f145d106s2
89–103
Actinoide
Actinides
104 *261.11
Rf
105 *262.11
Db
Product Information Sheet - B9808
and Sternglanz, R., Trends Genet., 10,
286-292 (1994).
8. Yang, X., et al., Cell, 89, 1067-1076 (1997).
9. Jahn, T., et al., Mol. Cell. Biol., 22, 979-991 (2002).
10. Kolanus, W., et al., Cell
Product Information Dulbecco’s Modified Eagle’s Medium (DMEM)
67-48-1 0.0040
17 Folic acid 59-30-3 0.0040
18 Myo-Inositol 87-89-8 0.0072
19 Nicotinamide 98-92-0 0.0040
20 Pyridoxine hydrochloride 58-56-0 0.0040
21 Riboflavin 83-88-5 0.0004
22 Thiamine hydrochloride
Novabiochem Innovations 03/10
PyBOP 60 31 5 4
PyOxim 10 45 5 40
HBTU 57 31 8 4
HCTU 31 35 9 25
HATU 0 16 7 77
TOTU 5 58 2 35
COMU 9 47 4
Protocol: Human GIP (Total) ELISA kit
125.4 111 89
148.9 224.9 200 89
444.4 520.4 481 90
2 0 58 58 100
49.4 107.4 93 87
148.9 206.9
Protocol- EZHGIP-54K|EZHGIP-54BK
49.4 125.4 111 89
148.9 224.9 200 89
444.4 520.4 481 90
2
0 58 58 100
49.4 107.4 93 87
148.9 206.9 167 81
444.4
Data Sheet - F0425
Natl. Acad. Sci. USA, 89, 246
(1992).
7. Johnson, D. E., et al., Mol. Cell Biol., 11, 4627
(1991).
8. Hanneken, A., et al., Proc. Natl. Acad. Sci. USA,
91, 9170 (1994).
9. Levi, E., et al.
Data Sheet - F0300
Natl. Acad. Sci. USA, 89, 246
(1992).
7. Johnson, D.E., et. al., Mol. Cell Biol., 11, 4627
(1991).
8. Hanneken, A., et al., Proc. Natl. Acad. Sci. USA,
91, 9170 (1994).
9. Levi, E., et al., Proc
Data Sheet - F6796
Natl. Acad. Sci. USA, 89, 246
(1992).
7. Johnson, D. E., et. al., Mol. Cell Biol., 11, 4627
(1991).
8. Hanneken, A., et al., Proc. Natl. Acad. Sci. USA,
91, 9170 (1994).
9. Levi, E., et. al.
Testing Lab & Industrial Flyer
Name CAS Application
429589 Acetone-2,4-dinitrophenylhydrazone environmental standard, 99% 1567-89-1 Analytical, Environmental, Standard
429554 Acetaldehyde-2,4-dinitrophenylhydrazone analytical
Validation and Qualification for Durapore® Sterilizing-Grade (0.22 µm) Membrane VMF4
.64 101
39 10.8 3.95 115 26 13.4 7.66 106
19 10.2 4.01 114 58 14.1 7.75 91
51 11.0 4.11 90 27 13.6 7.76 109
50 11.0 4.13 89 9 13.1 7.99 102
2
MM USP method compilation
Lansoprazole 53-57
Letrozole 58-64
Levofloxacin 65-68
Mefenamic Acid 69-72
Nifedipin 73-76
Olanzapine 77-81
Pantoprazole Sodium 82-88
Pioglitazone 89-96Pioglitazone 89-96
Terazosin 97-99
Merck Millipore
MILLIPLEX MAP Human High Sensitivity T Cell Panel
Competitor 100 6 100 50 88 50 94 100 75 25 100
Normal
(n=9)
MILLIPLEX® map 100 100 11 89 67 56 100 100 89 78 100
Competitor 89 0 33 22 78 22 33 89 22
Page 1 of 9